Injection-type compound bone repairing material containing more biological factors and using animal fibrin as carrier

A technology of biological factors and animal fibers, applied in the field of bone repair materials, can solve the problems of complex operation, limited scope of application, high cost, etc., and achieve the effects of good biological activity, wide range of clinical use, and low cost

Inactive Publication Date: 2002-10-30
孙明林
View PDF0 Cites 10 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] The existing method of using bone growth factor is to compound it on a solid material and implant it into the wound site through surgery. The operation is complica

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0016] Example 1: According to the technical scheme of the present invention, an injectable multiple biological factor composite bone repair material with animal fibrin as a carrier is prepared according to the following method:

[0017] 1) Aseptically take the anticoagulant blood of mammals such as pigs and cattle, separate the plasma and extract the fibrinogen by low-temperature centrifugation, freeze-drying to make spongy fibrinogen as the first part of the system;

[0018] 2) A certain dose of recombinant human bone morphogenetic protein, fibroblast growth factor and beta transforming growth factor are added to thrombin to form the second part of the system.

[0019] 3) The first part uses double-distilled water as the solvent to prepare a suspension before use; the concentration of fibrin is 70mg / ml;

[0020] 4) The second part uses 40mM / L calcium chloride as solvent, the concentration of thrombin is 500IU / ml, and the concentrations of recombinant human bone morphogenetic pro...

Example Embodiment

[0022] Example 2: According to the technical scheme of the present invention, an injectable multiple biological factor composite bone repair material with animal fibrin as a carrier is prepared according to the following method:

[0023] 1) Aseptically take the anticoagulant blood of mammals such as pigs and cattle, separate the plasma and extract the fibrinogen by low-temperature centrifugation, freeze-drying to make spongy fibrinogen as the first part of the system;

[0024] 2) A certain dose of recombinant human bone morphogenetic protein, fibroblast growth factor and beta transforming growth factor are added to thrombin to form the second part of the system.

[0025] 3) The first part uses double-distilled water as the solvent to prepare a suspension before use; the concentration of fibrin is 110mg / ml;

[0026] 4) The second part uses 40mM / L calcium chloride as solvent, the concentration of thrombin is 500IU / ml, and the concentrations of recombinant human bone morphogenetic pr...

Example Embodiment

[0028] Example 3: According to the technical scheme of the present invention, an injectable multiple biological factor composite bone repair material with animal fibrin as a carrier is prepared according to the following method:

[0029] 1) Aseptically take the anticoagulant blood of mammals such as pigs and cattle, separate the plasma and extract the fibrinogen by low-temperature centrifugation, freeze-drying to make spongy fibrinogen as the first part of the system;

[0030] 2) A certain dose of recombinant human bone morphogenetic protein, fibroblast growth factor and beta transforming growth factor are added to thrombin to form the second part of the system.

[0031] 3) The first part uses double-distilled water as the solvent to prepare a suspension before use; the concentration of fibrin is 90mg / ml;

[0032] 4) The second part uses 40mM / L calcium chloride as solvent, the concentration of thrombin is 500IU / ml, and the concentrations of recombinant human bone morphogenetic pro...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Concentrationaaaaaaaaaa
Login to view more

Abstract

An injection-type composite bone repair material for treating bone fracture, nonunion, dysostosis and osteoporosis contains the fibrin in mammal's blood as carrier, genetically recombinant bone morphogenetic protein, fibroblast growth factor and beta-converting growth factor. Its advantages are sure curative effect, wide application range and high safety.

Description

[0001] 1. Field [0002] The present invention relates to a bone repair material for medical clinical application, in particular to an injection-type material with animal fibrin as carrier which is used for clinical fracture, nonunion, bone defect, osteoporosis and other diseases and can be used in veterinary medicine A variety of biological factors composite bone repair material. 2. Background technology [0003] The existing method of using bone growth factor is to compound it on a solid material and implant it into the wound site through surgery. The operation is complicated, the cost is high, and the scope of application is limited, especially for closed fractures and other cases that do not require surgical treatment. Difficult to apply. 3. Contents of the invention [0004] According to the partial defects or deficiencies in the above-mentioned prior art, the object of the present invention is to provide a kind of animal fibrin-based fiber protein that is used for dis...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K38/18A61K47/42A61P19/08
Inventor 孙明林
Owner 孙明林
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap